Johnson & Johnson - COVID-19 Covered

Johnson & Johnson

Johnson & Johnson: Partnering with the Biomedical Advanced Research and Development Authority (BARDA) to commit more than $1 billion to coronavirus vaccine research and development.

Produced by Marathon Strategies, an independent PR firm that delivers intelligent communications and research solutions. For information, email Phil Singer at COVID-19@marathonstrategies.com